Castle Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CSTL and other ETFs, options, and stocks.

About CSTL

Castle Biosciences, Inc.is a molecular diagnostics company offering innovative test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, barrett’s esophagus, uveal melanoma, and in the treatment of mental health conditions. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. 

CEO
Derek J. Maetzold
CEODerek J. Maetzold
Employees
883
Employees883
Headquarters
Friendswood, Texas
HeadquartersFriendswood, Texas
Founded
2007
Founded2007
Employees
883
Employees883

CSTL Key Statistics

Market cap
632.99M
Market cap632.99M
Price-Earnings ratio
-46.85
Price-Earnings ratio-46.85
Dividend yield
Dividend yield
Average volume
372.89K
Average volume372.89K
High today
$20.95
High today$20.95
Low today
$20.24
Low today$20.24
Open price
$20.36
Open price$20.36
Volume
112.81K
Volume112.81K
52 Week high
$44.28
52 Week high$44.28
52 Week low
$14.59
52 Week low$14.59

Stock Snapshot

The current Castle Biosciences(CSTL) stock price is $20.87, with a market capitalization of 632.99M. The stock trades at a price-to-earnings (P/E) ratio of -46.85.

During the trading session on 2026-06-09, Castle Biosciences(CSTL) shares reached a daily high of $20.95 and a low of $20.24. At a current price of $20.87, the stock is +3.1% higher than the low and still -0.4% under the high.

Trading volume for Castle Biosciences(CSTL) stock has reached 112.81K, versus its average volume of 372.89K.

The stock's 52-week range extends from a low of $14.59 to a high of $44.28.

The stock's 52-week range extends from a low of $14.59 to a high of $44.28.

CSTL News

Investing.com 4d
Earnings call transcript: Castle Biosciences Q1 2026 sees revenue growth - Investing.com

...

Earnings call transcript: Castle Biosciences Q1 2026 sees revenue growth - Investing.com

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own CSTL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.